Edaravone inhibits neuronal ferroptosis and alleviates acute Central nervous system injury induced by diquat <i>via</i> enhancement of METTL14-mediated m6A methylation of Aldh1l1 by Liaozhang Wu (8371008)

“…<p>The biological effects of edaravone (Eda), a free radical scavenger, include anti-inflammatory, antioxidant, and neuroprotective qualities. …”

Stability differences between condition 1 and other conditions across participants on the non-hemiparetic side (NHP) side. by Hyung Suk Yang (20442438)

Stability differences between condition 1 and other conditions across participants on the hemiparetic (HP) side. by Hyung Suk Yang (20442438)

Experimental design and procedures. by Anita B. Frohlich (20660615)

Experimental design used in broiler chickens. by Oumayma Arbani (21001472)

“…This study demonstrates a clear clinical difference among the two isolates; A/chicken/Morocco/178-2/2022(H9N2) showed a significant increase in virulence compared to the firstly isolate A/chicken/Morocco/SF1/2016(H9N2). …”

Microscopical lesions in trachea and lungs H&E staining on dpi 5. by Oumayma Arbani (21001472)

Five <i>Sox10</i> ECs. by Hongjoo An (21703199)

TAD analysis for <i>Sox10.</i> by Hongjoo An (21703199)

Probability of Cost-Effectiveness Across CET. by Yiping An (20609789)

“…When the CET was relaxed to 0.90 times GDP per capita (US$11,284.476), the probability of cost-effectiveness for AOM after a 40% price reduction rose to 85.10%. Scenario analyses conducted over a time horizon extending from 10 to 30 years showed that the ICER decreased significantly with longer follow-up, gradually approaching the 0.51GDP threshold and remaining below the 0.90 GDP threshold throughout the analysis.…”

Base-case analysis. by Yiping An (20609789)

“…When the CET was relaxed to 0.90 times GDP per capita (US$11,284.476), the probability of cost-effectiveness for AOM after a 40% price reduction rose to 85.10%. Scenario analyses conducted over a time horizon extending from 10 to 30 years showed that the ICER decreased significantly with longer follow-up, gradually approaching the 0.51GDP threshold and remaining below the 0.90 GDP threshold throughout the analysis.…”

Temporal dynamics of Sox10-E1 and Sox10-E2 along the OL lineage. by Hongjoo An (21703199)

CRISPRi interrogation of the <i>Sox10</i> ECs. by Hongjoo An (21703199)

The original plotting data. by Hongmei Qian (538647)

“…<div><p>Background</p><p>Glaucoma, characterized by a high incidence and significant ocular harm, has been elucidated through various mechanisms. …”

Background characteristics of study participants. by Awole Seid (3839965)

“…</p><p>Conclusion</p><p>Symptoms vary in onset, severity, and pattern among individuals, significantly impacting their quality of life. Nutritional support is a pressing need for cancer patients. …”

Dataset. by Awole Seid (3839965)

“…</p><p>Conclusion</p><p>Symptoms vary in onset, severity, and pattern among individuals, significantly impacting their quality of life. Nutritional support is a pressing need for cancer patients. …”

Topographic maps of difference in individual alpha/mu power between breathing conditions. by Anita B. Frohlich (20660615)

Quantitative immunofluorescence of Sox10 in mouse OLs after CRISPRi knockdown of EC1 and EC2. by Hongjoo An (21703199)

Summary of codes generated from MAXQDA software. by Awole Seid (3839965)

“…</p><p>Conclusion</p><p>Symptoms vary in onset, severity, and pattern among individuals, significantly impacting their quality of life. Nutritional support is a pressing need for cancer patients. …”

Fabrication of Ionic Supramolecular Oleogel Lubricants Enhanced with Liquid Metal Nanodroplets for Superior Tribological Performance by Tiantian Wang (1688881)

“…Compared to the base oil PAO10, the coefficient of friction (COF) for both GLM@IGel-1 and GLM@IGel-2 decreased significantly from 0.192 to 0.097, while the wear volume dropped from 100.10 × 10⁴ μm³ to 13.28 × 10⁴ μm³ for GLM@IGel-1, and to 9.69 × 10⁴ μm³ for GLM@IGel-2. …”

Schematic presentation of themes and categories. by Awole Seid (3839965)

“…</p><p>Conclusion</p><p>Symptoms vary in onset, severity, and pattern among individuals, significantly impacting their quality of life. Nutritional support is a pressing need for cancer patients. …”